You can optimize your chances of pregnancy using genetic testing technology in conjunction with IVF. PGS/NGS is the testing of an embryo’s overall chromosomal normalcy prior to being transferred to the patient’s uterus. Specifically, PGS/NGS identifies the most suitable and healthiest embryo to transfer by detecting chromosomal deficiencies – aneuploidy – an extra or missing chromosome.
Universal blastocyst-stage PGS/NGS is recommended because the procedure can help increase the chances of a successful IVF pregnancy by 30 percent.
State-of-the-art embryo biopsy techniques and genetics technologies have proven to increase IVF pregnancy rates. Through the medical marvel of PGS/NGS in conjunction with IVF, genetic and chromosomal abnormalities can be detected in embryos.
As a woman advances in age, the chance for chromosomal abnormalities in embryos increases. Low quality embryos result in:
PGS/NGS takes place in conjunction with IVF in a controlled laboratory setting. Approximately five (5) days – blastocyst stage – after fertilization of the patient’s eggs in vitro, a single cell is removed from each of the embryos developing.
The benefits of PGS in conjunction with IVF include:
We offer the highest success rates and best overall patient satisfaction through PGS/NGS technology in conjunction with IVF. To schedule your initial consultation with Dr. John Zhang – call 917.525.5496.